Form EFFECT Semnur Pharmaceuticals,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | December 29, 2025 4:00 P.M. |
| Form: | S-1 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Dimensional Fund Advisors Ltd. : Form 8.3 - AMG CRITICAL MATERIALS N.V. - Ordinary Shares
- Form 8.3 -[ADVANCED MEDICAL SOLUTIONS GROUP PLC - 04 06 2026] - (CGWL)
- New Health Economic Evidence Shows Health & Cost Benefits When Starting Dialysis at Home
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
